trimethoprim has been researched along with ar-709 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, BC; Dealwis, CG; Lee, RE; Simmerman, RF; Xu, H | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
2 other study(ies) available for trimethoprim and ar-709
| Article | Year |
|---|---|
Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Topics: Amino Acid Sequence; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bacillus anthracis; Bacterial Proteins; Binding Sites; Crystallography, X-Ray; Cytosine; Humans; Methotrexate; Models, Molecular; Molecular Sequence Data; Protein Conformation; Sequence Alignment; Tetrahydrofolate Dehydrogenase; Trimethoprim Resistance | 2007 |
In vitro activity of AR-709 against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |